{"id":"https://openalex.org/W2089040344","doi":"https://doi.org/10.1046/j.1471-4159.1997.69062452.x","title":"Perlecan Binds to the \u03b2\u2010Amyloid Proteins (A\u03b2) of Alzheimer's Disease, Accelerates A\u03b2 Fibril Formation, and Maintains A\u03b2 Fibril Stability","display_name":"Perlecan Binds to the \u03b2\u2010Amyloid Proteins (A\u03b2) of Alzheimer's Disease, Accelerates A\u03b2 Fibril Formation, and Maintains A\u03b2 Fibril Stability","publication_year":1997,"publication_date":"1997-12-01","ids":{"openalex":"https://openalex.org/W2089040344","doi":"https://doi.org/10.1046/j.1471-4159.1997.69062452.x","mag":"2089040344","pmid":"https://pubmed.ncbi.nlm.nih.gov/9375678"},"language":"en","primary_location":{"id":"doi:10.1046/j.1471-4159.1997.69062452.x","doi":"https://doi.org/10.1046/j.1471-4159.1997.69062452.x","is_oa":false,"landing_page_url":"https://doi.org/10.1046/j.1471-4159.1997.69062452.x","pdf_url":null,"source":{"id":"https://openalex.org/S135837084","display_name":"Journal of Neurochemistry","issn_l":"0022-3042","issn":["0022-3042","1471-4159"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Neurochemistry","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101833343","display_name":"Gerardo M. Castillo","orcid":"https://orcid.org/0000-0003-0963-2859","observed_orcids":["https://orcid.org/0000-0003-0963-2859"]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gerardo M. Castillo","raw_affiliation_strings":["Neuropathology Laboratories, University of Washington, Seattle 98195-6480, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neuropathology Laboratories, University of Washington, Seattle 98195-6480, U.S.A","institution_ids":["https://openalex.org/I201448701"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Catherine Ngo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Catherine Ngo","raw_affiliation_strings":["Neuropathology Laboratories, University of Washington, Seattle, Washington, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neuropathology Laboratories, University of Washington, Seattle, Washington, U.S.A","institution_ids":["https://openalex.org/I201448701"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074811293","display_name":"Joel A. Cummings","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joel Cummings","raw_affiliation_strings":["Neuropathology Laboratories, University of Washington, Seattle, Washington, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neuropathology Laboratories, University of Washington, Seattle, Washington, U.S.A","institution_ids":["https://openalex.org/I201448701"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035268339","display_name":"Thomas N. Wight","orcid":"https://orcid.org/0000-0002-2794-4197","observed_orcids":["https://orcid.org/0000-0002-2794-4197"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Thomas N. Wight","raw_affiliation_strings":["Department of Pathology and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology and","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5019375169","display_name":"Alan D. Snow","orcid":"https://orcid.org/0000-0002-7333-3100","observed_orcids":["https://orcid.org/0000-0002-7333-3100"]},"institutions":[{"id":"https://openalex.org/I201448701","display_name":"University of Washington","ror":"https://ror.org/00cvxb145","country_code":"US","type":"education","lineage":["https://openalex.org/I201448701"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Alan D. Snow","raw_affiliation_strings":["Neuropathology Laboratories, University of Washington, Seattle, Washington, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neuropathology Laboratories, University of Washington, Seattle, Washington, U.S.A","institution_ids":["https://openalex.org/I201448701"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5019375169"],"corresponding_institution_ids":["https://openalex.org/I201448701"],"apc_list":{"value":5330,"currency":"USD","value_usd":5330},"apc_paid":null,"fwci":5.0082,"has_fulltext":false,"cited_by_count":272,"citation_normalized_percentile":{"value":0.96633539,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"69","issue":"6","first_page":"2452","last_page":"2465"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.9965999722480774,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11131","display_name":"Proteoglycans and glycosaminoglycans research","score":0.002400000113993883,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11142","display_name":"Advanced Glycation End Products research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1308","display_name":"Clinical Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/perlecan","display_name":"perlecan","score":0.9909999966621399},{"id":"https://openalex.org/keywords/amyloid-beta","display_name":"amyloid-beta","score":0.8949999809265137},{"id":"https://openalex.org/keywords/alzheimer-s-disease","display_name":"Alzheimer's disease","score":0.9570000171661377},{"id":"https://openalex.org/keywords/amyloid-fibril-formation","display_name":"amyloid fibril formation","score":0.9359999895095825},{"id":"https://openalex.org/keywords/heparan-sulfate-proteoglycans","display_name":"heparan sulfate proteoglycans","score":0.968999981880188},{"id":"https://openalex.org/keywords/abeta-1-40","display_name":"A\u03b2(1-40)","score":0.7310000061988831},{"id":"https://openalex.org/keywords/amyloid-beta-1-42","display_name":"amyloid-beta 42","score":1.0},{"id":"https://openalex.org/keywords/protein-protein-binding","display_name":"protein-protein binding","score":0.6930000185966492},{"id":"https://openalex.org/keywords/heparin","display_name":"heparin","score":0.7020000219345093},{"id":"https://openalex.org/keywords/glycosaminoglycans","display_name":"glycosaminoglycans","score":0.8450000286102295},{"id":"https://openalex.org/keywords/fibril-assembly","display_name":"fibril assembly","score":0.43700000643730164},{"id":"https://openalex.org/keywords/thioflavin-t-fluorescence","display_name":"thioflavin T fluorescence","score":0.6830000281333923},{"id":"https://openalex.org/keywords/amyloid-plaques","display_name":"amyloid plaques","score":0.5299999713897705}],"concepts":[{"id":"https://openalex.org/C22731427","wikidata":"https://www.wikidata.org/wiki/Q2071346","display_name":"Perlecan","level":4,"score":0.966198205947876},{"id":"https://openalex.org/C2778041096","wikidata":"https://www.wikidata.org/wiki/Q424668","display_name":"Heparan sulfate","level":3,"score":0.7350987792015076},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.7119582891464233},{"id":"https://openalex.org/C27523624","wikidata":"https://www.wikidata.org/wiki/Q14860849","display_name":"Fibril","level":2,"score":0.6951533555984497},{"id":"https://openalex.org/C2779553658","wikidata":"https://www.wikidata.org/wiki/Q408014","display_name":"Chondroitin sulfate","level":3,"score":0.5476077198982239},{"id":"https://openalex.org/C2777633098","wikidata":"https://www.wikidata.org/wiki/Q2736051","display_name":"Amyloid (mycology)","level":2,"score":0.5396722555160522},{"id":"https://openalex.org/C2779335624","wikidata":"https://www.wikidata.org/wiki/Q407976","display_name":"Proteoglycan","level":3,"score":0.5385056734085083},{"id":"https://openalex.org/C2778896982","wikidata":"https://www.wikidata.org/wiki/Q2033625","display_name":"Thioflavin","level":4,"score":0.49404147267341614},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.48765695095062256},{"id":"https://openalex.org/C153074725","wikidata":"https://www.wikidata.org/wiki/Q407553","display_name":"Glycosaminoglycan","level":2,"score":0.46312010288238525},{"id":"https://openalex.org/C2776174256","wikidata":"https://www.wikidata.org/wiki/Q830842","display_name":"BETA (programming language)","level":2,"score":0.4600616991519928},{"id":"https://openalex.org/C12554922","wikidata":"https://www.wikidata.org/wiki/Q7100","display_name":"Biophysics","level":1,"score":0.4094082713127136},{"id":"https://openalex.org/C502032728","wikidata":"https://www.wikidata.org/wiki/Q11081","display_name":"Alzheimer's disease","level":3,"score":0.23994696140289307},{"id":"https://openalex.org/C189165786","wikidata":"https://www.wikidata.org/wiki/Q193825","display_name":"Extracellular matrix","level":2,"score":0.19741889834403992},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.16070789098739624},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1528138518333435},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.0},{"id":"https://openalex.org/C179104552","wikidata":"https://www.wikidata.org/wiki/Q11165","display_name":"Inorganic chemistry","level":1,"score":0.0},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.0},{"id":"https://openalex.org/C199360897","wikidata":"https://www.wikidata.org/wiki/Q9143","display_name":"Programming language","level":1,"score":0.0},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000544","descriptor_name":"Alzheimer Disease","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D001667","descriptor_name":"Binding, Competitive","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006025","descriptor_name":"Glycosaminoglycans","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D006497","descriptor_name":"Heparan Sulfate","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D006497","descriptor_name":"Heparan Sulfate","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D006497","descriptor_name":"Heparan Sulfate","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D006497","descriptor_name":"Heparan Sulfate","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D010446","descriptor_name":"Peptide Fragments","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011509","descriptor_name":"Proteoglycans","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D011509","descriptor_name":"Proteoglycans","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011509","descriptor_name":"Proteoglycans","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016229","descriptor_name":"Amyloid beta-Peptides","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D016229","descriptor_name":"Amyloid beta-Peptides","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D016229","descriptor_name":"Amyloid beta-Peptides","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D019812","descriptor_name":"Heparan Sulfate Proteoglycans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1046/j.1471-4159.1997.69062452.x","doi":"https://doi.org/10.1046/j.1471-4159.1997.69062452.x","is_oa":false,"landing_page_url":"https://doi.org/10.1046/j.1471-4159.1997.69062452.x","pdf_url":null,"source":{"id":"https://openalex.org/S135837084","display_name":"Journal of Neurochemistry","issn_l":"0022-3042","issn":["0022-3042","1471-4159"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Neurochemistry","raw_type":"journal-article"},{"id":"pmid:9375678","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/9375678","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of neurochemistry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8560000061988831}],"study_designs":[],"awards":[{"id":"https://openalex.org/G6014117795","display_name":"RAT MODEL TO STUDY BETA/A4 AMYLOID DEPOSITION IN BRAIN","funder_award_id":"R01AG012953","funder_id":"https://openalex.org/F4320337337","funder_display_name":"National Institute on Aging"},{"id":"https://openalex.org/G7543209011","display_name":"BIOLOGY OF THE ARTERY WALL AND ATHEROSCLEROSIS","funder_award_id":"P01HL018645","funder_id":"https://openalex.org/F4320337338","funder_display_name":"National Heart, Lung, and Blood Institute"},{"id":"https://openalex.org/G7629573093","display_name":"Alzheimer's Disease Research Center","funder_award_id":"P50AG005136","funder_id":"https://openalex.org/F4320337337","funder_display_name":"National Institute on Aging"}],"funders":[{"id":"https://openalex.org/F4320337337","display_name":"National Institute on Aging","ror":"https://ror.org/049v75w11"},{"id":"https://openalex.org/F4320337338","display_name":"National Heart, Lung, and Blood Institute","ror":"https://ror.org/012pb6c26"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2053644101","https://openalex.org/W2159814060","https://openalex.org/W2412889958","https://openalex.org/W2103997070","https://openalex.org/W2023105561","https://openalex.org/W2056788982","https://openalex.org/W2087982057","https://openalex.org/W2417598856","https://openalex.org/W2395133223","https://openalex.org/W1981264235"],"abstract_inverted_index":{"Perlecan":[0,19,213,289],"is":[1],"a":[2,43,130,162,179,188,240,277],"specific":[3],"heparan":[4,148],"sulfate":[5,149],"proteoglycan":[6],"that":[7,323],"accumulates":[8],"in":[9,109,123,182,206,244,276,353,360],"the":[10,22,110,169,217,291,329,354],"fibrillar":[11],"beta-amyloid":[12],"(A":[13],"beta)":[14],"deposits":[15],"of":[16,113,137,171,219,232,269,297,332,356],"Alzheimer's":[17,361],"disease.":[18,362],"purified":[20],"from":[21],"Engelbreth-Holm-Swarm":[23],"tumor":[24],"was":[25,143,152,281,290],"used":[26],"to":[27,117,141,254,328],"define":[28],"perlecan's":[29,252,286],"interactions":[30],"with":[31,120,208,246,305],"A":[32,38,50,70,81,93,103,114,124,138,172,183,209,220,233,247,262,270,298,333,338,357],"beta":[33,39,51,71,82,94,104,115,125,139,173,184,210,221,234,248,263,271,299,339,358],"and":[34,84,151,201,227,267,280,295,317,342],"its":[35],"effects":[36,260],"on":[37,261],"fibril":[40,127,176,185,257,265,273,300,340],"formation.":[41],"Using":[42,161],"solid-phase":[44],"binding":[45,111,136],"immunoassay,":[46],"freshly":[47],"solubilized":[48],"full-length":[49],"peptides":[52],"bound":[53],"immobilized":[54],"perlecan":[55,118,142,147,167,324,352],"at":[56,192],"two":[57],"sites,":[58],"representing":[59],"both":[60],"high-affinity":[61],"[K(D)":[62,86],"=":[63,74,87,97],"approximately":[64,75],"5.8":[65],"x":[66,77,89,99],"10(-11)":[67],"M":[68,79,91,101],"for":[69,80,92,102,351],"(1-40);":[72,95],"K(D)":[73,96],"6.5":[76],"10(-12)":[78],"(1-42)]":[83,105],"lower-affinity":[85],"3.5":[88],"10(-8)":[90,100],"4.3":[98],"interactions.":[106],"An":[107],"increase":[108,122,181],"capacity":[112],"(1-40)":[116,140,174,211,264],"correlated":[119],"an":[121],"amyloid":[126,175,256,307,344],"formation":[128,218,266,301,341],"during":[129],"1-week":[131],"incubation":[132,190],"period.":[133],"The":[134],"high-capacity":[135],"similarly":[144],"observed":[145],"using":[146],"glycosaminoglycans":[150],"completely":[153],"abolished":[154],"by":[155,159,285],"heparin,":[156],"but":[157,335],"not":[158,325],"chondroitin-4-sulfate.":[160],"thioflavin":[163,236],"T":[164,237],"fluorometry":[165],"assay,":[166],"accelerated":[168,216],"rate":[170],"formation,":[177],"causing":[178],"significant":[180],"assembly":[186],"over":[187],"2-week":[189,241],"period":[191,243],"1":[193,197,225],"h":[194,226],"(2.8-fold":[195,204],"increase),":[196,200],"day":[198],"(3.6-fold":[199],"3":[202],"days":[203],"increase)":[205],"comparison":[207,245],"alone.":[212],"also":[214,282,336],"initially":[215],"(1-42)":[222,235,249,272],"fibrils":[223,345],"within":[224],"maintained":[228],"significantly":[229],"higher":[230],"levels":[231],"fluorescence":[238],"throughout":[239],"experimental":[242],"alone,":[250],"suggesting":[251],"ability":[253],"maintain":[255],"stability.":[258],"Perlecan's":[259],"maintenance":[268],"stability":[274],"occurred":[275],"dose-dependent":[278],"manner":[279],"mediated":[283],"primarily":[284],"glycosaminoglycan":[287],"chains.":[288],"most":[292],"effective":[293],"enhancer":[294],"accelerator":[296],"when":[302],"compared":[303],"directly":[304],"other":[306],"plaque":[308],"components,":[309],"including":[310],"apolipoprotein":[311],"E,":[312],"alpha1-antichymotrypsin,":[313],"P":[314],"component,":[315],"C1q,":[316],"C3.":[318],"This":[319],"study,":[320],"therefore,":[321],"demonstrates":[322],"only":[326],"binds":[327],"predominant":[330],"isoforms":[331],"beta,":[334],"accelerates":[337],"stabilizes":[343],"once":[346],"formed,":[347],"confirming":[348],"pivotal":[349],"roles":[350],"pathogenesis":[355],"amyloidosis":[359]},"counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":9},{"year":2018,"cited_by_count":9},{"year":2017,"cited_by_count":8},{"year":2016,"cited_by_count":8},{"year":2015,"cited_by_count":7},{"year":2014,"cited_by_count":10},{"year":2013,"cited_by_count":11},{"year":2012,"cited_by_count":9}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}